Should I Buy IAC? IAC 2026 Analysis

Should You Buy IAC Inc (IAC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

36.950

1 Day change

-1.81%

52 Week Range

41.860

Analysis Updated At

2026/01/29

Not a good buy right now for a beginner long-term investor who wants to put money to work immediately. The stock’s technicals are still bearish (negative/expanding MACD), fundamentals show declining revenue and losses in 2025/Q3, hedge funds are actively selling, and there are no near-term catalysts in the news. While options positioning looks bullish and the price is near support (which can create bounces), the setup is not strong enough to justify a fresh long-term buy at this moment.

Technical Analysis

Price is ~38.41 (closed), sitting below the pivot (39.513) and near support (S1 38.649, S2 38.116), which suggests downside pressure with a nearby “line-in-the-sand” support zone. - Momentum/Trend: MACD histogram -0.231 and negatively expanding → bearish momentum is strengthening, not stabilizing. - RSI: RSI_6 at 33.306 → weak/near-oversold, but not a confirmed reversal signal by itself. - Moving Averages: converging MAs → consolidation, but with MACD negative, the consolidation is not yet signaling an uptrend. - Probabilistic trend (pattern analogs): modest upside odds very near-term, but negative bias over a month (-2.3%). **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today. Net: Technical picture favors “avoid chasing” until momentum improves (MACD stops expanding negatively and price regains pivot ~39.5).

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options sentiment skews bullish (low put/call ratios on both open interest and volume), implying traders are positioned more for upside than downside. - Open interest: Calls 10,666 vs Puts 4,343 (PCR 0.41) → bullish positioning. - Daily volume is small (13 contracts total), but volume is elevated vs its 30-day average (5.14x), suggesting a notable spike in attention. - Implied vol (30D) 41.74 vs historical vol 26.25 → options are pricing larger-than-usual moves; IV percentile ~56 indicates mid-to-high relative pricing. Interpretation: options lean bullish, but the underlying price trend (MACD) is still bearish—this looks more like speculative upside interest than confirmed trend reversal.

Technical Summary

Sell

Buy

Positive Catalysts

Potential strategic actions: Management commentary (from prior analyst notes) that “everything is on the table” (asset sale/business win/legal outcomes) over the next 12–18 months could unlock value if executed.
MGM stake described as providing downside support by at least one analyst (UBS), potentially limiting worst-case downside.
Options positioning is bullish (very low put/call ratios), which can support short-term bounces.
Upcoming earnings: QDEC 2025 earnings on 2026-02-03 after hours (Est. EPS 0.67). A strong print or improved outlook could reset sentiment.

Neutral/Negative Catalysts

Fundamentals are weakening: 2025/Q3 revenue -8.13% YoY, net income still negative, EPS -0.27 (down ~90.78% YoY).
Bearish momentum: MACD is below zero and worsening; price is below pivot and leaning on support.
Institutional behavior: Hedge funds are selling, and selling increased ~304.76% over the last quarter.
Catalyst gap: No notable news in the past week; Oppenheimer explicitly cited “lack of near-term catalysts.”
Analyst caution: A recent downgrade to Perform (Oppenheimer) and multiple price-target cuts post-Q3 highlight continued uncertainty around growth/EBITDA trajectory.

Financial Performance

Latest quarter: 2025/Q3. - Revenue: 589.793M, down -8.13% YoY (top-line contraction). - Net income: -21.879M, down -91.02% YoY (still loss-making, deterioration vs prior year). - EPS: -0.27, down -90.78% YoY. - Gross margin: 59.31%, up +7.66% YoY (margin improvement is a positive, but it has not translated into profitability yet). Bottom line: improving gross margin is constructive, but the combination of shrinking revenue and continued losses is not the profile of a clean long-term entry today.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: mixed but tilting cautious. - Positive/Supportive: JPMorgan raised PT to $46 (Overweight); Jefferies raised PT to $45 (Buy). Several firms maintain Buy/Overweight despite trimming targets earlier (Benchmark, Truist, Barclays, KeyBanc). - Negative/Cautious: Oppenheimer downgraded to Perform from Outperform (no PT), citing valuation and minimal upside to 2026 estimates plus lack of near-term catalysts. UBS remains Neutral with PT $39. Wall Street pros vs cons summary: Pros: perceived asset/value optionality (sum-of-the-parts, potential actions), some belief in downside support (MGM stake), several Buy/Overweight ratings remain. Cons: near-term catalyst scarcity, messy execution signals post-Q3, uncertain growth/EBITDA trajectory, and at least one high-profile downgrade. Influential trading check: No recent congress trading data available; insiders are neutral (no significant recent trend).

9 Analyst Rating

Wall Street analysts forecast IAC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IAC is 48.11 USD with a low forecast of 39 USD and a high forecast of 60 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

2 Hold

0 Sell

Strong Buy

Current: 37.630

Low

Averages

48.11

High

Current: 37.630

Low

Averages

48.11

High

Oppenheimer

Outperform -> Perform

downgrade

AI Analysis

2025-12-15

Reason

Oppenheimer

Price Target

AI Analysis

2025-12-15

downgrade

Outperform -> Perform

Reason

Oppenheimer downgraded IAC to Perform from Outperform without a price target. The firm says IAC's sum-of-the-parts share discount is back to historical highs and there is minimal upside to 2026 estimates. It cites valuation and a lack of near-term catalysts for the downgrade.

JPMorgan

NULL -> Overweight

maintain

$43 -> $46

2025-12-12

Reason

JPMorgan

Price Target

$43 -> $46

2025-12-12

maintain

NULL -> Overweight

Reason

JPMorgan raised the firm's price target on IAC to $46 from $43 and keeps an Overweight rating on the shares. The firm adjusted ratings and targets in the small- and mid-cap internet and video games group as part of its 2026 outlook.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for IAC

Unlock Now

IAC Should I Buy

IAC Should I Buy

Should You Buy IAC Inc (IAC) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch